Shows effective treatment for multiple myeloma in younger individuals, indicating better outcomes.
High-dose therapy with autologous stem-cell rescue is an effective first-line treatment for patients with multiple myeloma who are younger than 65 years of age.
No takes yet. Share an insight, caveat, or question.
Child et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: